1
项与 Anti-GFRA4 CAR-T (University of Pennsylvania) 相关的临床试验Phase I Trial of GFRα4 CAR T Cells in Adult Patients With Recurrent or Metastatic Medullary Thyroid Cancer
This is an open-label phase 1 study to assess the safety and feasibility of autologous T cells expressing a single-chain scFv targeting GFRα4 with tandem TCR/CD3ζ and 4-1BB (TCRζ/4-1BB) co-stimulatory domains (referred to as "CART-GFRa4 cells") in patients with incurable medullary thyroid cancer (MTC).
100 项与 Anti-GFRA4 CAR-T (University of Pennsylvania) 相关的临床结果
100 项与 Anti-GFRA4 CAR-T (University of Pennsylvania) 相关的转化医学
100 项与 Anti-GFRA4 CAR-T (University of Pennsylvania) 相关的专利(医药)
100 项与 Anti-GFRA4 CAR-T (University of Pennsylvania) 相关的药物交易